Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children

S M Schmidt1, C E Müller, R Bruns

  • 1Department of Paediatrics, Children's and Youth Hospital, Ernst-Moritz-Arndt University, Greifswald, Germany.

Insights

Respiratory Chlamydia pneumoniae infection (RCPI) is common in children but not linked to allergic asthma markers. However, weakly positive RCPI cases show higher allergic sensitization and lung function impairment, suggesting a role in childhood asthma development.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Diseases
  • Allergology

Background:

  • The association between respiratory Chlamydia pneumoniae infection (RCPI) and childhood asthma remains debated.
  • Understanding RCPI prevalence and its link to asthma markers in pediatric respiratory illnesses is crucial.

Purpose of the Study:

  • To determine the frequency of RCPI in children with recurrent/chronic bronchitis or pneumonia.
  • To investigate the association between RCPI and asthma indicators, including eosinophilic inflammation, immunoglobulin E levels, and lung function.

Main Methods:

  • Polymerase chain reaction (PCR) on tracheobronchial aspirates for RCPI detection in 106 children.
  • Assessment of eosinophilic inflammation (cytology, ECP), total and specific IgE, and lung function tests.
  • Categorization of PCR results into positive, weak positive, and negative for RCPI.

Main Results:

  • RCPI was detected in 51.9% of children; 25.4% were weak positives.
  • Children with RCPI showed less nasal eosinophilia and lower total IgE levels.
  • Weakly positive RCPI cases exhibited the highest allergic sensitization rates and impaired lung function, particularly in adolescents.

Conclusions:

  • RCPI is prevalent in this pediatric cohort but not directly associated with allergic respiratory inflammation.
  • Weakly positive RCPI cases represent a distinct group with significant allergic sensitization and lung function abnormalities.
  • Early diagnosis and treatment of RCPI in children, especially weak positives, may be important for managing potential asthma development.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...